National Heart, Lung, and Blood Institute Notice of Meeting, 43883 [2018-18549]
Download as PDF
<![CDATA[
43883
Federal Register / Vol. 83, No. 167 / Tuesday, August 28, 2018 / Notices
ANNUALIZED BURDEN HOUR TABLE
Average
burden per
response
(within hours)
Total burden
hours
Respondents
Grantee key informant interview
guides.
Partner campus key informant interview guides.
Grantee organization representative
9
1
1
9
Partner campus representative ........
36
1
1
36
...........................................................
........................
........................
........................
45
Total ...........................................
Terry Clark,
Asst Reduction Act Reports Clearance Officer,
Office of the Secretary.
[FR Doc. 2018–18544 Filed 8–27–18; 8:45 am]
BILLING CODE 4150–33–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Complementary and
Integrative Health.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
daltland on DSKBBV9HB2PROD with NOTICES
Number of
responses per
respondents
Number of
respondents
Forms
Name of Committee: National Advisory
Council for Complementary and Integrative
Health.
Date: October 5, 2018.
Closed: 8:30 a.m. to 9:45 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Conference Room 10, 31 Center
Drive, Bethesda, MD 20892.
Open: 10:00 a.m. to 4:00 p.m.
Agenda: A report from the Institute
Director and other staff.
VerDate Sep<11>2014
20:00 Aug 27, 2018
Jkt 244001
Place: National Institutes of Health,
Building 31, Conference Room 10, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Partap Singh Khalsa,
Ph.D., DC, Director, Division of Extramural
Activities, National Center for
Complementary and Integrative Health, NIH,
National Institutes of Health, 6707
Democracy Blvd., Ste. 401, Bethesda, MD
20892–5475, (301) 594–3462, khalsap@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
nccih.nih.gov/about/naccih/, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Integrative Health,
National Institutes of Health, HHS)
Dated: August 22, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Sickle Cell Disease
Advisory Committee.
Date: November 16, 2018.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: Presentations and Discussion of
Programs.
Place: National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, 9th Floor,
Room 9100/9104, Bethesda, MD 20892.
Contact Person: W. Keith Hoots, MD,
Director, Division of Blood Diseases and
Resources, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Suite 9030,
Bethesda, MD 20892, 301–435–0080,
hootswk@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: August 22, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–18549 Filed 8–27–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2018–18548 Filed 8–27–18; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Sickle Cell Disease
Advisory Committee.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Clinical Trials
and Translational Research Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 83, Number 167 (Tuesday, August 28, 2018)]
[Notices]
[Page 43883]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-18549]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Sickle Cell Disease
Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Sickle Cell Disease Advisory Committee.
Date: November 16, 2018.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: Presentations and Discussion of Programs.
Place: National Heart, Lung, and Blood Institute, 6701 Rockledge
Drive, 9th Floor, Room 9100/9104, Bethesda, MD 20892.
Contact Person: W. Keith Hoots, MD, Director, Division of Blood
Diseases and Resources, National Heart, Lung, and Blood Institute,
6701 Rockledge Drive, Suite 9030, Bethesda, MD 20892, 301-435-0080,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: August 22, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-18549 Filed 8-27-18; 8:45 am]
BILLING CODE 4140-01-P
